In a significant leap for sustainable technology, a research team led by Northwestern University has unveiled a groundbreaking microbial fuel…
Read More
Madrigal Pharmaceuticals Secures Global Rights to Arrowhead’s siRNA Asset for MASH, Paving Way for Combination Therapy Exploration
Madrigal Pharmaceuticals has significantly bolstered its pipeline for metabolic dysfunction-associated steatohepatitis (MASH) by acquiring the global rights to Arrowhead Pharmaceuticals’…
Read More
Science News: A Century of Empowering Public Understanding of Science
Since its founding in 1921, Science News has stood as a beacon of independent, nonprofit journalism, dedicated to delivering accurate…
Read More
Baptists and Bootleggers: The Hidden Coalition Behind ‘Data-Driven’ Decisions
In the contemporary corporate landscape, the assertion of being "data-driven" has become a powerful declaration, often serving as the ultimate…
Read More
GLP-1 Receptor Agonists and the Emerging Question of Anticancer Effects
The rapidly expanding landscape of drugs designed to mimic glucagon-like peptide-1 (GLP-1), famously exemplified by Ozempic and Wegovy, is increasingly…
Read More
The BioTechniques 2026 Image Competition is Now Open for Entries, Celebrating the Intersection of Scientific Innovation and Visual Art.
BioTechniques, a leading journal in life science methods and innovation, has officially opened submissions for its highly anticipated 2026 Image…
Read More
Canadian Researchers Identify Potential Breakthrough in Glioblastoma Treatment Using Repurposed HIV Medication
A collaborative team of scientists from McMaster University and The Hospital for Sick Children (SickKids) has uncovered a significant biological…
Read More
Scientists Solve the Two-Century-Old Dolomite Problem by Unlocking the Secret of Pulsed Crystal Growth
A collaborative team of researchers from the University of Michigan and Hokkaido University has finally resolved one of the most…
Read More
AI Lab Result Interpretation Gains Traction with Patients, but Raises Accuracy and Validation Concerns for Clinical Laboratories
The burgeoning integration of artificial intelligence into daily life is profoundly reshaping how individuals interact with complex medical information, particularly…
Read More
UCB Acquires Candid Therapeutics for Up to $2.2 Billion to Bolster Autoimmune Disease Pipeline with Novel T-Cell Engagers
UCB’s strategic move to acquire Candid Therapeutics for an initial $2 billion upfront, with an additional $200 million in milestone…
Read More
